ArticleSensors (Basel, Switzerland)2026
Trans-D3: A Novel Hybrid Transformer-Based Actor-Critic Approach for Remaining Useful Life Prediction.
Article in Sensors (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The present article introduces TRANS-D3, an innovative hybrid method that combines the Twin Delayed Deep Deterministic Policy Gradient (TD3) reinforcement learning algorithm with the Transformer architecture for predicting the remaining useful life (RUL). The model utilizes an optimized reward function based on the Linear Quadratic Regulator (LQR) to approach error correction as a dynamic control problem. On the CMAPSS dataset, TRANS-D3 demonstrates a marked advantage, achieving RMSE reductions of 84-90% in baseline situations (FD001) and 23-45% in highly variable contexts (FD003/FD004). Statistical validation demonstrates high reliability, with a coefficient of determination R2 of more than 0.93 in each of the subsets; the maximum is 0.9984 in FD001. The 95% confidence intervals for the mean error, ranging from [0.709 to 1.244] in FD001 and from [-1.324 to 1.748] in FD004, also confirm that the framework is a statistically unbiased estimator. In terms of Score, the model reduces penalties by between 80% and 95% compared to advanced architectures such as DAST or STAR, ensuring very stable predictions. These findings present a novel robust optimization paradigm, which is essential for ensuring the safety and reliability of complex industrial systems in the context of Industry 4.0.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.